Prognostically, high Galectin-9 expression is associated with longer survival in gastric cancer, yet marks T-cell exhaustion and poorer outcomes in non-small-cell lung cancer, underscoring the context-dependent nature of this lectin’s immune regulation [22,23]. This evidence concerns the gene LGALS9 and gastric cancer.